Recursion ipo
WebRecursion Pharmaceuticals has raised a total of $615.4M in funding over 17 rounds. Their latest funding was raised on Oct 25, 2024 from a Post-IPO Equity round. Recursion … WebApr 16, 2024 · Recursion had initially planned to raise $306 million through the sale of 18 million shares priced in the range of $16 to $18 a share but raised the number of shares offered ahead of the IPO. Existing investors Baillie Gifford, on behalf of Scottish Mortgage Investment Trust, and Mubadala Investment Company had said they planned to buy up to ...
Recursion ipo
Did you know?
WebRecursion is an Equal Opportunity Employer that values diversity and inclusion. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal ... WebIncluding the underwriters’ option of 3.6 million shares, Recursion sold 27.878 million shares at $18/share, raising nearly $502 million in the process (before IPO expenses). However, Recursion shares opened at $26.32 when actual trading began on April 16th, not at $18, a nearly 50% pop. And as of market close today, Recursion stock was priced at …
WebMar 28, 2024 · Recursion is the clinical-stage biotechnology company industrializing drug discovery by decoding biology. Enabling its mission is the Recursion OS, a platform built … WebApr 13, 2024 · Recursion Pharmaceuticals is going bigger than expected in its initial public offering. After initially indicating it intended to raise $100 million in its Nasdaq debut, the …
WebSep 21, 2024 · The IPO markets for most of the 2000s never warmed up much. Jazz Pharma, now a high flying $8B company, “took it on the chin” when it went public in 2007, nearly 30% below its target range ... WebDrug discovery startup Recursion raises $60 million in Series B from Data CollectiveTechCrunch - Oct, 3 2024. EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Some data ...
WebApr 12, 2024 · Recursion Pharmaceuticals Proposes $306 Million U.S. IPO Financial Status. Recursion’s recent financial results are more or less typical of a clinical-stage biopharma …
WebThe Recursion Data Universe: As of March 22, 2024, our Recursion Data Universe contained nearly eight petabytes of highly relatable biological and chemical data spanning multiple different data modalities. The size of the Recursion Data Universe has grown more than threefold since 2024 and has continued to grow at an accelerating rate. For ... how do you catch mumpsWebJun 15, 2024 · Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering. Our goal is... pho recipe tastyWebMar 30, 2024 · Utah’s hottest biotech firm, Recursion Pharmaceuticals, is taking advantage of the red hot stock market as it has announced plans for a $100 million Initial Public Offering. Over $1 billion and 12 years: and yet, on average, only 1 … pho red deerWebMay 17, 2024 · This came just a few months after Recursion raised $436 million in an upsized IPO in April 2024 (Table 1). Exscientia, a pioneer in applying AI to small-molecule drug design, had a hefty IPO... how do you catch paddlefishWebApr 13, 2024 · Recursion Pharmaceuticals IPO Recursion Pharmaceuticals is going bigger than expected in its initial public offering. After initially indicating it intended to raise $100 million in its Nasdaq debut, the Salt Lake City-based company will now look at bringing in approximately $306 million. pho recipe with star aniseWebMar 23, 2024 · Recursion Pharmaceuticals filed its S-1 paperwork late Monday, coming about six months after completing a $239 million Series D round and securing a deal with Bayer worth up to $1... how do you catch pancreatic cancer earlyWebApr 16, 2024 · Recursion Pharmaceuticals Inc., which uses machine learning to hunt for new therapies, raised $436 million in an upsized initial public offering priced at the top of a marketed range. The Salt Lake City-based company sold about 24 million shares on Thursday for $18 each, according to data compiled by Bloomberg. how do you catch pityriasis rosea